ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
18.437,30
-0,47%
S&P 500
5.588,27
-1,39%
Dow Jones
41.198,08
0,59%
Euro vs US Dollar
1,09415
0,37%
Bitcoin
64.354,75
-1,13%
Registration Strip Icon for discussion Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. USOTC
  6. Qrons Inc (QB) (QRON)

  7. Qrons Inc (QB) (QRON) News

QRON

Qrons (QB) (QRON)

Qrons Inc (QB)
Von:
Sortieren nach:
 Showing the most relevant articles for your search:USOTC:QRON
DatumZeitQuelleÜberschriftSymbolFirma
12/08/202303h36Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]USOTC:QRONQrons Inc (QB)
25/07/202317h14InvestorsHub BioTech NewsWireQrons Announces the Signing of a License Agreement Term Sheet as Part of New Research Program to Experiment and Commercialize the Therapeutic Effect of Certain Tellurium Based Compounds on Antibiotic Resistance Bacterial Infections, Sepsis and TBIsUSOTC:QRONQrons Inc (QB)
25/07/202317h14InvestorsHub NewsWireQrons Announces the Signing of a License Agreement Term Sheet as Part of New Research Program to Experiment and Commercialize the Therapeutic Effect of Certain Tellurium Based Compounds on Antibiotic Resistance Bacterial Infections, Sepsis and TBIsUSOTC:QRONQrons Inc (QB)
24/07/202321h24Edgar (US Regulatory)Form 8-K - Current reportUSOTC:QRONQrons Inc (QB)
15/05/202320h38Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
22/12/202221h31Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:QRONQrons Inc (QB)
22/12/202221h27Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:QRONQrons Inc (QB)
14/11/202219h20Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
15/08/202221h41Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
16/05/202219h39Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
28/03/202219h22Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:QRONQrons Inc (QB)
22/03/202211h04Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:QRONQrons Inc (QB)
18/03/202222h30Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:QRONQrons Inc (QB)
14/01/202221h05Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:QRONQrons Inc (QB)
11/01/202212h05Edgar (US Regulatory)Notice of Effectiveness (effect)USOTC:QRONQrons Inc (QB)
01/12/202119h32Edgar (US Regulatory)Securities Registration Statement (s-1)USOTC:QRONQrons Inc (QB)
15/11/202123h35Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
16/08/202119h59Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
13/05/202123h12Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
31/03/202121h46Edgar (US Regulatory)Annual Report (10-k)USOTC:QRONQrons Inc (QB)
16/12/202016h52Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:QRONQrons Inc (QB)
16/11/202019h31Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
14/08/202020h54Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
15/05/202022h35Edgar (US Regulatory)Quarterly Report (10-q)USOTC:QRONQrons Inc (QB)
30/03/202017h05Edgar (US Regulatory)Annual Report (10-k)USOTC:QRONQrons Inc (QB)
26/12/201921h22Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:QRONQrons Inc (QB)
26/12/201921h05Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:QRONQrons Inc (QB)
20/12/201916h36Edgar (US Regulatory)Current Report Filing (8-k)USOTC:QRONQrons Inc (QB)
19/12/201912h01Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)USOTC:QRONQrons Inc (QB)
18/12/201900h44Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:QRONQrons Inc (QB)
 Showing the most relevant articles for your search:USOTC:QRON

Kürzlich von Ihnen besucht

NASDAQ
GOOGL
Alphabet
TG
BAS
BASF
AMEX
XLV
Health Care Select Sector
COIN
BTCUSD
Bitcoin
TG
NOV
Novo Nordisk
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
USOTC
RHHBY
Roche (QX)
CCOM
SILVER
SILVER
NASDAQ
MSFT
Microsoft
FX
EURGBP
Euro vs Sterling
TG
DBK
Deutsche Bank
TG
CBK
Commerzbank
USOTC
DTEGY
Deutsche Telekom (QX)
NYSE
NKE
Nike
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2024 ADVFN PLC - Alle Rechte vorbehalten